Diagnostic Development & Evaluation

Experts in developing your new product to market

Ridgeway has a history of developing and evaluating various diagnostic tests.  From quantitative ELISA tests for progesterone measurement to modified faecal egg counts to evaluate cestode infections. 

Long-standing expertise in diagnostic development

In 2012 RRL developed a novel lateral flow diagnostic for progesterone measurement in milk, named P4Rapid which was sold as a stand-alone product in the agriculture industry across the globe; P4Rapid has been replaced with P4Gold.

Ridgeway Science has recently re-optimised a progesterone ELISA (in milk, serum and plasma) that the company originally developed. After re-optimisation, the assay was re-validated in-house using guidelines to calculate LOB, LOD, and LOQ.

How can we help you to get your diagnostic to market?

We have a proven track record and can facilitate the development of a new or existing diagnostic using multiple platforms and evaluate in-house or in the field to validate the product’s approval to market. Field studies can be designed, conducted and analysed to assess tests without a gold standard reference test.

Maggie Fisher reviewed the regulatory requirements for veterinary diagnostic tests and platforms in Regulation of Diagnostics in Animal Health (IAHJ Vol 4 Issue 2 24 – 29), meaning RRL is well versed with the requirements and can use these to improve your product’s chance to market.